CeriBell, Inc. (CBLL)
(Delayed Data from NSDQ)
$12.91 USD
+0.33 (2.62%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $12.92 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, CeriBell, Inc. has a market cap of $461.23M, which represents its share price of $12.58 multiplied by its outstanding shares number of 36.66M. As a small-cap company, CBLL's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CBLL 12.91 +0.33(2.62%)
Will CBLL be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CBLL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CBLL
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm
CBLL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CBLL
CeriBell GAAP EPS of -$0.38 beats by $0.02, revenue of $21.2M beats by $0.75M
Ceribell outlines $85M–$88M 2025 revenue target while expanding pediatric and neonate pilots
CeriBell, Inc. (CBLL) Q2 2025 Earnings Call Transcript
Ceribell (CBLL) Boosts Revenue Forecast for 2025
Ceribell (CBLL) Surpasses Q2 Revenue Expectations, Plans for Future Expansion